CVRx, Inc. Operating Cash Flow
CVRx, Inc. (CVRX) reported Operating Cash Flow of -$20.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- CVRx, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$8.83M.
- CVRx, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$12.16M.
- CVRx, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$9.76M.
- CVRx, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$9.71M.
- CVRx, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$40.17M.
- CVRx, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$39.14M.
- CVRx, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$39.02M.
- CVRx, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$42.68M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$20.99M 10-Q · filed 2026-08-06 | -$30.75M derived: sum of 3 quarters · filed 2026-08-06 | -$40.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$12.16M 10-Q · filed 2026-05-12 | -$21.92M derived: sum of 2 quarters · filed 2026-05-12 | -$31.63M derived: sum of 3 quarters · filed 2026-05-12 | -$39.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$19.47M derived: sum of 2 quarters · filed 2026-02-13 | -$27.40M derived: sum of 3 quarters · filed 2026-08-06 | -$40.17M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$9.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$17.64M derived: sum of 2 quarters · filed 2026-08-06 | -$30.41M 10-Q · filed 2025-11-06 | -$38.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$7.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$20.70M 10-Q · filed 2026-08-06 | -$28.71M derived: sum of 3 quarters · filed 2026-08-06 | -$39.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$12.77M 10-Q · filed 2026-05-12 | -$20.77M derived: sum of 2 quarters · filed 2026-05-12 | -$31.18M derived: sum of 3 quarters · filed 2026-05-12 | -$41.02M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$8.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$18.42M derived: sum of 2 quarters · filed 2026-02-13 | -$28.25M derived: sum of 3 quarters · filed 2026-02-13 | -$39.14M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$10.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$20.24M derived: sum of 2 quarters · filed 2025-11-06 | -$31.14M 10-Q · filed 2025-11-06 | -$38.98M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$9.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$20.73M 10-Q · filed 2025-08-05 | -$28.57M derived: sum of 3 quarters · filed 2025-08-05 | -$36.69M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$10.90M 10-Q · filed 2025-05-09 | -$18.73M derived: sum of 2 quarters · filed 2025-05-09 | -$26.86M derived: sum of 3 quarters · filed 2025-05-09 | -$39.67M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$15.96M derived: sum of 2 quarters · filed 2025-02-18 | -$28.77M derived: sum of 3 quarters · filed 2025-02-18 | -$39.02M 10-K · filed 2025-02-18 |
| 2023-09-30 | -$8.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$20.93M derived: sum of 2 quarters · filed 2024-11-01 | -$31.18M 10-Q · filed 2024-11-01 | -$42.02M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$23.06M 10-Q · filed 2024-08-02 | -$33.90M derived: sum of 3 quarters · filed 2024-08-02 | -$44.99M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$10.25M 10-Q · filed 2024-05-10 | -$21.09M derived: sum of 2 quarters · filed 2024-05-10 | -$32.19M derived: sum of 3 quarters · filed 2024-05-10 | -$42.28M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | -$21.94M derived: sum of 2 quarters · filed 2024-02-09 | -$32.03M derived: sum of 3 quarters · filed 2024-02-09 | -$42.68M 10-K · filed 2024-02-09 |
| 2022-09-30 | -$11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$21.19M derived: sum of 2 quarters · filed 2023-10-31 | -$31.84M 10-Q · filed 2023-10-31 | -$38.85M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | -$10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$20.74M 10-Q · filed 2023-08-03 | -$27.75M derived: sum of 3 quarters · filed 2023-08-03 | -$36.97M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$10.64M 10-Q · filed 2023-05-11 | -$17.66M derived: sum of 2 quarters · filed 2023-05-11 | -$26.87M derived: sum of 3 quarters · filed 2023-05-11 | -$33.34M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$16.23M derived: sum of 2 quarters · filed 2023-02-10 | -$22.69M derived: sum of 3 quarters · filed 2023-02-10 | -$27.73M 10-K · filed 2023-02-10 |
| 2021-09-30 | -$9.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$15.68M derived: sum of 2 quarters · filed 2022-11-04 | -$20.72M 10-Q · filed 2022-11-04 | -$24.80M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$6.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | -$11.50M 10-Q · filed 2022-08-01 | -$15.59M derived: sum of 3 quarters · filed 2022-08-01 | -$20.74M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | -$5.04M 10-Q · filed 2022-05-02 | -$9.12M derived: sum of 2 quarters · filed 2022-05-02 | -$14.28M derived: sum of 3 quarters · filed 2022-05-02 | |
| 2020-12-31 | -$4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$9.24M derived: sum of 2 quarters · filed 2022-02-22 | -$16.10M 10-K · filed 2022-02-22 | |
| 2020-09-30 | -$5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$12.01M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$6.86M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |